Stock Events

Stock Events

Codexis 

$1.72
0
+$0.09+5.52% Today

Statistics

Day High
1.72
Day Low
1.59
52W High
-
52W Low
-
Volume
29,065
Avg. Volume
-
Mkt Cap
155.36M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30AprExpected
Q3 2025
Q4 2025
Next
-0.22
-0.11
0
0.11
Expected EPS
-0.1575
Actual EPS
N/A

Financials

-109.99%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
118.69MRevenue
-130.55MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CDXS.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zymeworks BC
ZYME
Mkt Cap1.45B
Zymeworks Inc. is involved in the development of biotherapeutics, competing with Codexis in the biocatalyst market for pharmaceuticals.
Evotec
EVO
Mkt Cap1.46B
Evogene Ltd. focuses on the development of products for various life science markets, including the use of computational predictive biology, overlapping with Codexis' enzyme optimization technologies.
BNY Mellon Strategic Municipal Bond Fund
DSM
Mkt Cap0
Koninklijke DSM N.V. is a global science-based company active in health, nutrition, and materials, including biotechnology solutions that compete with Codexis' offerings.
Novonesis AS
NVZMY
Mkt Cap27.97B
Novozymes A/S is a world leader in bioinnovation and industrial enzymes, directly competing with Codexis in the development and production of novel enzymes.
DuPont de Nemours
DD
Mkt Cap34.19B
DuPont de Nemours, Inc. offers technology-based materials, ingredients, and solutions, including biotechnology products that compete with Codexis in the industrial biotech space.
Symrise
SYIEY
Mkt Cap11.91B
Symrise AG is engaged in producing flavors and fragrances, enzymes, and cosmetic ingredients, competing with Codexis in the specialty enzymes market.

About

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Show more...
CEO
ISIN
US1920051067

Listings

F
DE
4QK.F
XNAS
US
CDXS
LSE
GB
0I0X.LSE
BOATS
BOATS
CDXS.BOATS

0 Comments

Share your thoughts

FAQ

What is Codexis stock price today?▼
The current price of CDXS.BOATS is $1.72 USD — it has increased by +5.52% in the past 24 hours. Watch Codexis stock price performance more closely on the chart.
What is Codexis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Codexis stocks are traded under the ticker CDXS.BOATS.
What is Codexis market cap?▼
Today Codexis has the market capitalization of 155.36M
When is the next Codexis earnings date?▼
Codexis is going to release the next earnings report on April 30, 2026.
What were Codexis earnings last quarter?▼
CDXS.BOATS earnings for the last quarter are 0.11 USD per share, whereas the estimation was -0.03 USD resulting in a +466.67% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Codexis revenue for the last year?▼
Codexis revenue for the last year amounts to 118.69M USD.
What is Codexis net income for the last year?▼
CDXS.BOATS net income for the last year is -130.55M USD.
When did Codexis complete a stock split?▼
Codexis has not had any recent stock splits.